Celldex

$23.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.04%) Today
-$0.06 (-0.26%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Celldex and other stocks, options, and ETFs commission-free!

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.

CEO
Anthony S. Marucci
Employees
125
Headquarters
Hampton, New Jersey
Founded
1983
Market Cap
850.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
342.33K
High Today
$24.17
Low Today
$22.94
Open Price
$23.57
Volume
310.20K
52 Week High
$30.17
52 Week Low
$1.87

CLDX Earnings

-$0.90
-$0.60
-$0.30
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

NDP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure